When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
INVVY - Indivior's Sublocade shows treatment benefit in opioid use disorder study; shares up 2%
Indivior PLC ADR
Results from an open-label, long-term safety and tolerability study of Indivior PLC's (OTCPK:INVVY+1.6%) SUBLOCADE (buprenorphine extended-release) in patients with moderate-to-severe opioid use disorder demonstrated its positive effect on quality-of-life measures. The data were presented at the American Society of Addiction Medicine Annual Conference in San Diego, CA.
More news on: INDIVIOR PLC ADR, Healthcare stocks news, Stocks on the move,